This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Etude de phase IIa dans la maladie de Huntington visant à évaluer le potentiel thérapeutique du resvératrol. Phase IIa study in Huntington disease to evaluate the therapeutic potential of resveratrol
Investments > €500k
France
Huntington’s disease
2016